RB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.746640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.825610E-01
Normal-vs-Stage2
2.093200E-01
Normal-vs-Stage3
4.967600E-02
Normal-vs-Stage4
4.899600E-01
Stage1-vs-Stage2
7.979400E-01
Stage1-vs-Stage3
7.481600E-03
Stage1-vs-Stage4
4.971000E-01
Stage2-vs-Stage3
<1E-12
Stage2-vs-Stage4
4.576000E-01
Stage3-vs-Stage4
2.419600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.422210E-01
Normal-vs-AfricanAmerican
4.101600E-01
Normal-vs-Asian
2.189800E-01
Caucasian-vs-AfricanAmerican
4.873000E-01
Caucasian-vs-Asian
7.862800E-01
AfricanAmerican-vs-Asian
5.193000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.838000E-01
Normal-vs-Female
1.772750E-01
Male-vs-Female
9.026400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.268430E-01
Normal-vs-Age(41-60Yrs)
3.300000E-01
Normal-vs-Age(61-80Yrs)
1.412040E-01
Normal-vs-Age(81-100Yrs)
5.866000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.277200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.803400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.230000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.671220E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.337200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.773200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.048800E-01
Normal-vs-Daily Drinker
1.645870E-02
Normal-vs-Weekly Drinker
1.166960E-01
Normal-vs-Occasional Drinker
4.608800E-01
Normal-vs-Social Drinker
5.367000E-01
Non Drinker-vs-Daily Drinker
2.049800E-01
Non Drinker-vs-Weekly Drinker
5.841800E-01
Non Drinker-vs-Occasional Drinker
2.705400E-01
Non Drinker-vs-Social Drinker
1.468800E-01
Daily Drinker-vs-Weekly Drinker
6.562000E-01
Daily Drinker-vs-Occasional Drinker
5.907600E-02
Daily Drinker-vs-Social Drinker
1.867930E-02
Weekly Drinker-vs-Occasional Drinker
2.179400E-01
Weekly Drinker-vs-Social Drinker
1.317980E-01
Occasional Drinker-vs-Social Drinker
7.792800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.304400E-02
Normal-vs-Grade 2
1.546200E-02
Normal-vs-Grade 3
1.963830E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.307400E-01
Grade 1-vs-Grade 3
3.090800E-01
Grade 1-vs-Grade 4
7.304400E-02
Grade 2-vs-Grade 3
3.624200E-01
Grade 2-vs-Grade 4
1.546200E-02
Grade 3-vs-Grade 4
1.963830E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.174160E-01
Normal-vs-NonDiabetic
1.674640E-01
Diabetic-vs-NonDiabetic
5.994000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.832300E-02
Normal-vs-NoPancreatitis
1.783800E-01
Pancreatitis-vs-NoPancreatitis
1.931360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.411420E-01
Normal-vs-N1
2.103600E-01
N0-vs-N1
6.124200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.860200E-01
Normal-vs-TP53-NonMutant
2.289800E-01
TP53-Mutant-vs-TP53-NonMutant
2.723000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
